Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2026-01-04 @ 4:07 PM
Study NCT ID:
NCT02300103
Status:
COMPLETED
Last Update Posted:
2018-11-16
First Post:
2014-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09-15
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-20
First Submit QC Date:
None
Study First Post Date:
2014-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-30
Results First Submit QC Date:
None
Results First Post Date:
2017-07-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-19
Last Update Post Date:
2018-11-16
Last Update Post Date Type:
ACTUAL